by April Breyer Menon | Dec 5, 2017
Download PDF ...
by April Breyer Menon | Dec 5, 2017
Ha Kung Wong and Amanda Forys provide an overview of the Patent Trial and Appeal Board’s role in patent disputes over biologics, as part of The Center for Biosimilars™ Peer Exchange®. Ha Kung Wong has extensive experience litigating a wide variety...
by April Breyer Menon | Dec 4, 2017
Ha Kung Wong, Molly Burich, Amanda Forys, and Angus Worthing discuss reactions surrounding the enactment of state laws concerning the eventual substitution of interchangable biosimilars for reference products as part of The Center for Biosimilars™ Peer Exchange®....
by April Breyer Menon | Nov 28, 2017
On November 27, 2017, the Supreme Court heard oral argument in Oil States Energy Services, LLC v. Greene’s Energy Group, LLC, No. 16-712. The Supreme Court’s decision in this case will either spare or strike down inter partes review as a means for challenging the...
by April Breyer Menon | Nov 28, 2017
Ha Kung Wong, Molly Burich, Amanda Forys, and Angus Worthing discuss the potential fate of the Biologics Price Competition and Innovation Act (BPCIA) in health care reform efforts, and remark on negative feedback related to the Affordable Care Act (ACA) provision for...
by April Breyer Menon | Nov 20, 2017
Ha Kung Wong, Amanda Forys, and Angus Worthing discuss commercial hurdles that may affect the coverage and use of alternative biosimilar products in the rheumatology market as part of the The Center for Biosimilars™ Peer Exchange®. Ha Kung Wong...